Skip to main content
OpenTrials
Completed

NCT Number: NCT04745078

Carboxytherapy for Periorbital Dark Circles

the study evaluates carboxytherapy for the treatment of periorbital dark circles

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Periorbital Disorder

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Medicine,Alexandria University

Alexandria, Egypt

About this study

two different concentrations of carboxytherapy administered to patients are compared regarding efficacy

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy individuals with dark circles

Exclusion criteria

  • infections, scarring, pregnancy, allergy, on treatment for the condition.

Treatment and study plan

Caboxy30

Other

carboxy30 to periorbital dark halos

Other names: Carboxy30

Caboxy60

Other

carboxy60 to periorbital dark halos

Primary outcomes

  1. Improvement of Melanin index

    Time frame: 6 weeks

    change in melanin index of the dark circles

  2. Improvement of erythema index

    Time frame: 6 weeks

    change in erythema index of the dark circles

Sponsors and collaborators

Lead sponsor

Alexandria University

Other

Registry information

Official study title

Evaluation of the Use of Carboxytherapy in Periorbital Dark Circles

Important dates

Study start
2017
Primary completion
2021
Study completion
2021
First posted
Feb 9, 2021
Registry last updated
Nov 4, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.